24, 2025 — A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical ...
It’s recommended those who are between 32 weeks and 36 weeks pregnant get one dose of the maternal RSV vaccine, Abrysvo, administered September through January. Adults 75 and older and those 60 ...
Companies say they are working to update their products to comply with the Food and Drug Administration's decision Wednesday to ban the artificial food dye Red 3, after the agency said it was ...
It's recommended those who are between 32 weeks and 36 weeks pregnant get one dose of the maternal RSV vaccine, Abrysvo, administered September through January. Adults 75 and older and those 60-74 ...
Another year of sinking revenue isn't what investors were expecting last May when mRESVIA, its respiratory syncytial virus (RSV) vaccine, earned approval from the Food and Drug Administration (FDA ...
The Thai Food and Drug Administration (FDA) issued a warning about the dangers of Pot K, a vape liquid mixed with ketamine, which can be fatal. Selling this substance can lead to a prison sentence of ...
HealthDay News — The U.S. Food and Drug Administration now requires and has approved safety labeling changes to the prescribing information for the Abrysvo (Pfizer) and Arexvy (GlaxoSmithKline) ...
FDA says baby food should contain no more than 10 parts per billion of lead. HealthDay News — The first-ever U.S. Food and Drug Administration guidelines on lead in baby food are under fire from ...
"This is an area where we are continuing to invest, and I think the science and the effectiveness of this drug is proven," Davis said. "It is truly seen globally as an anti-cancer vaccine.
Hosted on MSN16d
FDA Adds Warning Label to RSV Vaccines Abrysvo and ArexvyMONDAY, Jan. 13, 2025 (HealthDay News) -- The U.S. Food and Drug Administration ... for the Abrysvo (Pfizer) and Arexvy (GlaxoSmithKline) respiratory syncytial virus (RSV) vaccines to include ...
FDA adds warning label to RSV vaccines Abrysvo and Arexvy about the risk for Guillain-Barré syndrome
The U.S. Food and Drug Administration ... prescribing information for the Abrysvo (Pfizer) and Arexvy (GlaxoSmithKline) respiratory syncytial virus (RSV) vaccines to include warnings and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback